Passa al contenuto
Merck

T4071

L-Threonine

Sinonimo/i:

(2S,3R)-2-Amino-3-hydroxybutyric acid

Slide 1 of 2
Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

100 G

478,00 €

1 KG

1.860,00 €

10 KG

10.220,00 €

25 KG

21.900,00 €

478,00 €

Per informazioni sulla disponibilità, contatta il Servizio Clienti.
Richiedi un ordine in blocco

Informazioni su questo articolo

Formula condensata:
CH3CH(OH)CH(NH2)CO2H
Numero CAS:
72-19-5
Peso molecolare:
119.12
EC Number:
200-774-1
UNSPSC Code:
12352209
NACRES:
NA.26
Beilstein/REAXYS Number:
1721646
MDL number:
MFCD00064270

Documenti fondamentali

Visualizza tutta la documentazione

Vai a

Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti

InChI key

AYFVYJQAPQTCCC-GBXIJSLDSA-N

InChI

1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1

SMILES string

C[C@@H](O)[C@H](N)C(O)=O

biological source

non-animal source

assay

≥98.5%

form

crystalline powder

technique(s)

cell culture | mammalian: suitable

impurities

endotoxin, heavy metals, trace metals, residual solvents, tested

mp

256 °C (dec.) (lit.)

solubility

H2O: 50 mg/mL

suitability

suitable for manufacturing use

foreign activity

cytotoxicity, tested

Quality Level

400

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 4

Questo articolo
61506PHR1242T8441
L-Threonine

SAFC

T4071

L-Threonine

L-Threonine certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

Supelco

61506

L-Threonine

L-Threonine Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1242

L-Threonine

L-Threonine from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0%

Sigma-Aldrich

T8441

L-Threonine

biological source

non-animal source

biological source

-

biological source

-

biological source

non-animal source

form

crystalline powder

form

-

form

-

form

powder

assay

≥98.5%

assay

-

assay

-

assay

99.0-101.0%

impurities

endotoxin, heavy metals, trace metals, residual solvents, tested

impurities

-

impurities

-

impurities

endotoxin, tested

suitability

suitable for manufacturing use

suitability

-

suitability

-

suitability

-

foreign activity

cytotoxicity, tested

foreign activity

-

foreign activity

-

foreign activity

-

Application

L-Threonine is a β-hydroxy-α-amino acid. It is an essential amino acid and can be used as a cell culture media component for the commercial biomanufacture of therapeutic recombinant proteins and monoclonal antibodies.

General description

Our SAFC® portfolio of high-quality raw materials for use in biopharmaceutical processing withstands strict quality control procedures plus the documentation and expertise to help our customers meet requirements as defined by the M-Clarity Program.

M-Clarity Program

Our comprehensive portfolio of upstream process chemicals not only provides biopharmaceutical manufacturers with high-quality raw materials for production of classical and novel therapies, but also helps them get to market faster and simplify regulatory challenges. Trust us to deliver supply chain transparency and reliable sourcing around the globe, streamlining your product qualification with best-in-class regulatory support and service.
To request documentation for this product, please contact Customer Support and select ‘Product Documentation′. Please note that access to documentation for this product requires a confidentiality disclosure agreement.

Legal Information

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
CDBG8841
CDBG8842
CDBG8569
CDBG8523
CDBG8283

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Tamara Seredenina et al.
Antioxidants & redox signaling, 23(5), 490-513 (2014-02-04)
Voltage-gated proton channels are increasingly implicated in cellular proton homeostasis. Proton currents were originally identified in snail neurons less than 40 years ago, and subsequently shown to play an important auxiliary role in the functioning of reactive oxygen species (ROS)-generating
Sarah Schmidt et al.
Journal of leukocyte biology, 98(1), 5-14 (2015-02-04)
The deoxynucleoside triphosphate triphosphohydrolase and 3' → 5' exonuclease SAMHD1 restricts HIV-1 infection in noncycling hematopoietic cells in vitro, and SAMHD1 mutations are associated with AGS. Little is known about the in vivo expression and functional regulation of this cellular
Chang-Ching Liu et al.
Molecular and cellular biology, 34(1), 57-70 (2013-10-30)
In budding yeast (Saccharomyces cerevisiae), the cell cycle-dependent telomere elongation by telomerase is controlled by the cyclin-dependent kinase 1 (Cdk1). The telomere length homeostasis is balanced between telomerase-unextendable and telomerase-extendable states that both require Cdc13. The recruitment of telomerase complex
Mario Ost et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 29(4), 1314-1328 (2014-12-11)
Recent studies on mouse and human skeletal muscle (SM) demonstrated the important link between mitochondrial function and the cellular metabolic adaptation. To identify key compensatory molecular mechanisms in response to chronic mitochondrial distress, we analyzed mice with ectopic SM respiratory
Anne-Sophie Van Rompuy et al.
Journal of neuropathology and experimental neurology, 73(2), 159-174 (2014-01-16)
Mutations in the parkin gene are the most common cause of early-onset autosomal recessive Parkinson disease (PD). The pathogenic mechanisms of how parkin mutations lead to the development of PD are not fully understood. Studies of cell cultures and of
Visualizza tutti i documenti correlati

Domande

Recensioni

Nessuna valutazione

Filtri attivi

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica